1. "2022"
Formats
  1. Journal Article (2449)
  2. Meeting Abstract (2196)
  3. Review (615)
  4. Editorial (363)
  5. Book Section (139)
  6. Correspondence (117)
  7. Guidelines (112)
  8. Research Letter (82)
  9. Miscellaneous (60)
  10. Conference Paper (29)
  11. Book Whole (6)
Groups
  1. Department of Medicine (2621)
  2. Solid Tumor Oncology Division (1573)
  3. Sloan Kettering Institute Postdocs (1364)
  4. GSK Faculty (1152)
  5. Surgery (1036)
  6. Hematologic Malignancies, Division of (964)

More Groups

People
  1. Miguel-Angel Perales (95)
  2. Alexander Drilon (85)
  3. Saad Usmani (83)
  4. Sergio Giralt (77)
  5. Marc Ladanyi (72)
  6. Gilles Salles (69)

More People

Years
  1. 2022 (6168)
Publications
  1. Journal of Clinical Oncology (520)
  2. Blood (319)
  3. Cancer Research (191)
  4. Annals of Oncology (158)
  5. Annals of Surgical Oncology (134)
  6. International Journal of Radiation Oncology, Biology, Physics (132)

More Publications

Publishers
  1. Elsevier Inc. (794)
  2. American Society of Clinical Oncology (583)
  3. Springer (440)
  4. Nature Publishing Group (379)
  5. American Society of Hematology (369)
  6. Oxford University Press (360)

More Publishers

Results (6168)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Primary results from TROPiCS-02: A randomized phase 3 study of sacituzumab govitecan (SG) versus treatment of physician's choice (TPC) in patients (Pts) with hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer
    Meeting Abstract

    Rugo, H. S.; Bardia, A.; Marine, F.; Cortes, J.; Schmid, P.; Loirat, D.; Tredan, O.; Ciruelos, E.; Dalenc, F.; Pardo, P. G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • SKYSCRAPER-02: Primary results of a phase III, randomized, double-blind, placebo-controlled study of atezolizumab (atezo) + carboplatin + etoposide (CE) with or without tiragolumab (tira) in patients (pts) with untreated extensive-stage small cell lung cancer (ES-SCLC)
    Meeting Abstract

    Rudin, C. M.; Liu, S. V.; Lu, S.; Soo, R. A.; Hong, M. H.; Lee, J. S.; Bryl, M.; Dumoulin, D. W.; Rittmeyer, A.; Chiu, C. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The impact of bowel preparation on surgical site infection rates in gynecologic oncology surgery, post-hoc analysis from a randomized controlled trial
    Meeting Abstract

    Moukarzel, L.; Nguyen, N.; Zhou, Q.; Ramesh, B.; Chi, D.; Sonoda, Y.; Brown, A.; Abu-Rustum, N.; Mueller, J.; Roche, K. L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Assessment of safety and biodistribution of AAVrh.10hCLN2 following intracisternal administration in nonhuman primates for the treatment of CLN2 Batten disease
    Meeting Abstract

    Sondhi, D.; Rosenberg, J. B.; De, B. P.; Kooner, V.; Wilson, I.; Yusufzai, N.; Kaminsky, S. M.; Arbona, R. J. R.; Monette, S.; Nair, A.; more...
    Human Gene Therapy (2022)

    Fulltext@MSK | Save
  • NGS-based chimerism analysis challenges and solutions: Donor cell contamination in post-transplant buccal swabs
    Meeting Abstract

    Blouin, A. G.; Askar, M.; Ye, F.; Nelson, W.; Geraghty, D.
    Human Immunology (2022)

    Fulltext@MSK | Save
  • Evidence-based guidelines increase uptake and decrease racial disparities in endometrioid endometrial cancer patients electing ovarian preservation
    Meeting Abstract

    Manning-Geist, B.; Rios-Doria, E.; Aviki, E.; Zhou, Q.; Abu-Rustum, N.; Brown, C.; Mueller, J.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Will ovarian transposition become the forceps of gynecologic oncology? A survey of the Society of Gynecologic Oncology members
    Meeting Abstract

    Gordhandas, S.; Kahn, R.; Broach, V.; Leitao, M.; Roche, K. L.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Postoperative morbidity after secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer: An exploratory analysis of a randomized phase II study evaluating hyperthermic intraperitoneal chemotherapy
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Chi, D.; Sonoda, Y.; Roche, K. L.; Gardner, G.; Tew, W.; Grisham, R.; O'Cearbhaill, R.; Zivanovic, O.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • The RECOURSE study: Long-term oncologic outcomes associated with robotically-assisted minimally invasive hsyterectomy performed in patients with endometrial cancer: A meta-analysis
    Meeting Abstract

    Leitao, M.; Kreaden, U.; Rossi, E.; Hebert, A.; Slee, A.; Gonen, M.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Oncologic outcomes of secondary cytoreductive surgery in the era of poly (ADP-ribose) polymerase inhibitors maintenance
    Meeting Abstract

    Ehmann, S.; Lam, C.; Zhou, Q.; Grisham, R.; Roche, K. L.; Zivanovic, O.; Sonoda, Y.; Chi, D.; Gardner, G.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save